Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 14/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.45 |
| ▸ | MAPT | P10636 | 10/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 12/20 | 0.42 |
| ▸ | MEN1 | O00255 | 8/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.42 |
| ▸ | PKM | P14618 | 7/20 | 0.42 |
| ▸ | GAA | P10253 | 7/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 5/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.42 |
| ▸ | GLA | P06280 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | CASP1 | P29466 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | CASP7 | P55210 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22579091 | 0.83 | ALDH1A1 (0.48) | KDM4EALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL21722540 | 0.80 | ALDH1A1 (0.46) | KDM4EALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL20666152 | 0.74 | ALDH1A1 (0.43) | KDM4EALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL20658616 | 0.72 | ALDH1A1 (0.52) | KDM4EALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL30738272 | 0.71 | ADORA2A (0.42) | KDM4EALDH1A1HPGDGAAHSD17B10 | |
| SCHEMBL20392820 | 0.71 | ADORA2A (0.42) | KDM4EALDH1A1HPGDGAAHSD17B10 | |
| SCHEMBL20658479 | 0.70 | KDM4E (0.36) | KDM4EALDH1A1HPGDGAAHSD17B10 | |
| SCHEMBL21722433 | 0.69 | KDM4E (0.38) | KDM4EALDH1A1MAPTMAPK1HPGD | |
| SCHEMBL8895760 | 0.69 | LMNA (0.40) | KDM4EALDH1A1HPGDGAAHSD17B10 | |
| SCHEMBL10782113 | 0.68 | USP8 (0.38) | KDM4EHTTUSP8SMN1; SMN2RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292285-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | NUVATION BIO INC (US) | 2021-09-23 | — | — | US | disclosed |
| US-11028058-B2 | Heterocyclic compounds as adenosine antagonists | NUVATION BIO INC. (US) | 2021-06-08 | — | — | US | disclosed |
| EP-3654978-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | Nuvation Bio Inc. (US) | 2020-05-27 | — | — | EP | disclosed |
| CN-111163780-A | Heterocyclic compounds as adenosine antagonists | 诺维逊生物股份有限公司 | 2020-05-15 | — | — | CN | disclosed |
| WO-2019018584-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | GiraFpharma LLC (US) | 2019-01-24 | — | — | WO | disclosed |
| US-20190023666-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT (CA) | 2019-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190023666-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | ADORA2A, ADORA3, ADORA1 | KDM4E 4200/4885ALDH1A1 2100/4885MAPT 4850/4885 |
| US-11028058-B2 | Heterocyclic compounds as adenosine antagonists | ADORA2A, ADORA3, ADORA1 | KDM4E 4200/4885ALDH1A1 2100/4885MAPT 4850/4885 |
| US-20210292285-A1 | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS | ADORA2A, ADORA3, ADORA1 | KDM4E 4200/4885ALDH1A1 2100/4885MAPT 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.